WARWICK – Biomedical Structures LLC, developer of biomedical textiles for medical devices and other advanced clinical applications, announced March 6 that it was new capabilities for the high-precision development and manufacturing of vascular grafts.
“With the ability to taper very fine fabrics, BMS creates straight and bifurcated tubes for woven grafts supporting endovascular stent systems designed to prevent abdominal aortic aneurysm rupture, as well as for other percutaneous-coronary intervention stent procedures and peripheral vascular grafts throughout the extremities. Tapered tubes more naturally match human anatomy and allow device designers to marry specific dimensions to aortic geometries to more closely mimic functional shape,” the company said in a statement.
Beyond Cash Donations: How New Forms of Giving Are Transforming Not-for-Profit Accounting
Evolving Funding Landscape for Not-for-Profits Not-for-profit organizations are being asked to do more with less,…
Learn More
According to a report cited in the news release, there is a large market for peripheral vascular devices – expcted to grow to more than $7.1 billion in 2018; the market for stent grafs, including abdominal aortic aneurysm and thoracic aortic aneurysm stent grafts, is expected to double in value.
“BMS strives to consistently deliver on our commitment to expanding our medical textile engineering capabilities for device OEMs looking to more precise, tailored solutions,” said BMS CEO Dean Tulumaris. “Now device OEMs will be able to utilize vascular grafts with a very specific geometry for successful stent support and more lifelike properties. We will continue to enhance our capacity to handle very fine bio-absorbable and permanent fibers and shape them to match human anatomy as closely as possible within the body.”
